Unum Therapeutics Inc. (UMRX)
(Delayed Data from NSDQ)
$3.35 USD
+0.07 (2.13%)
Updated May 3, 2019 04:13 PM ET
After-Market: $3.32 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Cogent Biosciences, Inc. [UMRX]
Reports for Purchase
Showing records 1 - 20 ( 55 total )
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
CORRECTED: Upgrading to OUTPERFORM; UMRX Gets a Break of that KIT(-Kat Bar)
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Awaiting Clinical Validation for the BOXR Platform
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Downgrading to NEUTRAL; Will this BOXR Get Off the Mat?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
ASH 2019: Key Presentations Roundup for Covered Companies Days 1-2
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Initial Solid Tumor Data on Track to Readout by Year end
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A